Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

Jacob N, Targan SR, Shih DQ.

United European Gastroenterol J. 2016 Aug;4(4):531-40. doi: 10.1177/2050640616649356. Epub 2016 May 10. Review.

2.

Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn's disease and leprosy.

Sun Y, Irwanto A, Toyo-Oka L, Hong M, Liu H, Andiappan AK, Choi H, Hitomi Y, Yu G, Yu Y, Bao F, Wang C, Fu X, Yue Z, Wang H, Zhang H, Kawashima M, Kojima K, Nagasaki M, Nakamura M, Yang SK, Ye BD, Denise Y, Rotzschke O, Song K, Tokunaga K, Zhang F, Liu J.

Sci Rep. 2016 Aug 10;6:31429. doi: 10.1038/srep31429.

3.

Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis.

Williams JO, Wang EC, Lang D, Williams AS.

Pharmacol Res Perspect. 2016 Jun 10;4(4):e00240. eCollection 2016 Aug.

4.

The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Ward-Kavanagh LK, Lin WW, Šedý JR, Ware CF.

Immunity. 2016 May 17;44(5):1005-19. doi: 10.1016/j.immuni.2016.04.019. Review.

PMID:
27192566
5.

Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.

Sidhu-Varma M, Shih DQ, Targan SR.

Inflamm Bowel Dis. 2016 Mar;22(3):548-59. doi: 10.1097/MIB.0000000000000653.

PMID:
26818423
6.

Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.

Miller PG, Bonn MB, McKarns SC.

J Immunol. 2015 Sep 15;195(6):2633-47. doi: 10.4049/jimmunol.1500286. Epub 2015 Aug 12.

PMID:
26268655
7.

The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator.

Richard AC, Ferdinand JR, Meylan F, Hayes ET, Gabay O, Siegel RM.

J Leukoc Biol. 2015 Sep;98(3):333-45. doi: 10.1189/jlb.3RI0315-095R. Epub 2015 Jul 17. Review.

8.

Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.

Ahn YO, Weeres MA, Neulen ML, Choi J, Kang SH, Heo DS, Bergerson R, Blazar BR, Miller JS, Verneris MR.

Eur J Immunol. 2015 Aug;45(8):2335-42. doi: 10.1002/eji.201445213. Epub 2015 Jun 22.

9.

NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation.

Yu HB, Yurieva M, Balachander A, Foo I, Leong X, Zelante T, Zolezzi F, Poidinger M, Ricciardi-Castagnoli P.

Nucleic Acids Res. 2015 Jan;43(2):836-47. doi: 10.1093/nar/gku1369. Epub 2014 Dec 30.

10.

TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells.

Wang J, Al-Lamki RS, Zhu X, Liu H, Pober JS, Bradley JR.

BMC Nephrol. 2014 Nov 16;15:178. doi: 10.1186/1471-2369-15-178.

11.

The role of death receptor 3 in the biological behavior of hepatocellular carcinoma cells.

Zhang YC, Guo LQ, Chen X, Wang GN, Ni R, Wang MC, Wei FX.

Mol Med Rep. 2015 Feb;11(2):797-804. doi: 10.3892/mmr.2014.2858. Epub 2014 Nov 4.

12.

R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice.

Schmitz K, de Bruin N, Bishay P, Männich J, Häussler A, Altmann C, Ferreirós N, Lötsch J, Ultsch A, Parnham MJ, Geisslinger G, Tegeder I.

EMBO Mol Med. 2014 Sep 30;6(11):1398-422. doi: 10.15252/emmm.201404168.

13.

Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis.

Ray S, De Salvo C, Pizarro TT.

Curr Opin Gastroenterol. 2014 Nov;30(6):531-8. doi: 10.1097/MOG.0000000000000119. Review.

14.

Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Ślebioda TJ, Kmieć Z.

Mediators Inflamm. 2014;2014:325129. doi: 10.1155/2014/325129. Epub 2014 Jun 17. Review.

15.

Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3.

Wang EC, Newton Z, Hayward OA, Clark SR, Collins F, Perks WV, Singh RK, Twohig JP, Williams AS.

Arthritis Rheumatol. 2014 Oct;66(10):2762-72. doi: 10.1002/art.38770.

16.

CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.

Longman RS, Diehl GE, Victorio DA, Huh JR, Galan C, Miraldi ER, Swaminath A, Bonneau R, Scherl EJ, Littman DR.

J Exp Med. 2014 Jul 28;211(8):1571-83. doi: 10.1084/jem.20140678. Epub 2014 Jul 14.

17.

Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.

Liu C, Li XX, Gao W, Liu W, Liu DS.

PLoS One. 2014 Mar 20;9(3):e92743. doi: 10.1371/journal.pone.0092743. eCollection 2014.

18.

The role of TL1A and DR3 in autoimmune and inflammatory diseases.

Aiba Y, Nakamura M.

Mediators Inflamm. 2013;2013:258164. doi: 10.1155/2013/258164. Epub 2013 Dec 21. Review.

19.

TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF⁺ leukocytes.

Reichwald K, Jørgensen TZ, Tougaard P, Skov S.

PLoS One. 2014 Jan 8;9(1):e85793. doi: 10.1371/journal.pone.0085793. eCollection 2014.

20.

The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.

Meylan F, Hawley ET, Barron L, Barlow JL, Penumetcha P, Pelletier M, Sciumè G, Richard AC, Hayes ET, Gomez-Rodriguez J, Chen X, Paul WE, Wynn TA, McKenzie AN, Siegel RM.

Mucosal Immunol. 2014 Jul;7(4):958-68. doi: 10.1038/mi.2013.114. Epub 2013 Dec 25.

Items per page

Supplemental Content

Write to the Help Desk